Physicians' Academy for Cardiovascular Education

Lp(a) as independent causal risk factor: why should we focus on testing?

Listen to the podcast
10' education - Oct. 11, 2022 - Prof. Florian Kronenberg, MD, PhD – Innsbruck, Austria

Video navigation menu

  • Why should we measure Lp(a) concentrations? 00:16
  • Challenges in determining Lp(a) levels 01:29
  • Rationale for risk thresholds 08:51
  • Do we need genetic testing? 11:14
  • Concluding remarks 14:03


Show transcript

Educational information

This lecture by Prof. Florian Kronenberg was part of the EBAC-accredited symposium "Lp(a): from causality to therapy" held during the ESC congress 2022.


Prof Kronenberg is full professor and head of the Institute of Genetic Epidemiology at the Medical University of Innsbruck. His main research interests are genetic and clinical epidemiological studies on lipoprotein(a) as one of the most important genetic risk factors for cardiovascular disease.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by unrestricted educational grants from NewAmsterdam Pharma, Novartis, Sanofi and Roche Diagnostics.

View the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: